|
A possible new cancer treatment developed at the University of Alberta is expected to be heading to human trials at three Canadian cancer centres, before year's end.
The new phase in the drug’s development would be made possible thanks to $5 million in funding from Edmonton-based investors.
The drug, known as PCLX-001, comes in pill form and is designed to fight blood cancers like leukemia and lymphoma.
|